EQS-News: CRMI: Acornea Conquers the Darkness Innovation brings light to the blind around the world

EQS-News / 17/10/2016 / 12:20 UTC+8 
 
*Acornea Conquers the Darkness* 
*Innovation brings light to the blind around the world* 
Chicago, Illinois, October 16th 
 
*An Eye-Opennijg innovation: *Acornea makes a breakthrough in regenerative 
medicine as an innovation with the world's first bio-engineered cornea that 
brings light to the blind. The product is named as Acornea by China 
Regenerative Medicine International, a medical group based in Hong Kong. 
 
*The product: *Cornea is the clear outer covering of the eyeball. Acornea is 
a bio-engineered product that can be used as a replacement of human cornea 
for the blind to see again. The main body of Acornea is derived from other 
animals such as pigs and biologically treated to make it compatible to 
humans. 
Other advantages of Acornea are the following special features: great 
transparency, less likely to get affected, easy to store and transport, and 
it does not require any kind of preserving fluid or complicated storage 
conditions. Moreover, the greatest benefit to the patients is that patients 
do not have to use lifelong immunosuppressive drugs after Acornea procedure 
in contrast with the human cornea transplant. Acornea has already been 
successfully used in curing patients. 
 
*It proves to be working.* The past 2 years witnessed 200 patients who have 
received Acornea transplant in China ranging from 11 month infant to 
70-year-old adult. The result turned out to be successful. What is more 
inspiring is that the technology has been repeatedly proven to be effective, 
and it is now ready for global market. 
 
*The scientist: *So much appreciation should go to Dr. Shi, weiyun, 
professor from China Regenerative Medicine International. Dr. Shi is the 
Chairman of China Medical Association and the director of Cornea Medicine 
and Studies. As a world famous scientist at the top, Dr. Shi has been 
practicing eye medicine for more than 30 years and has conducted more than 
10,000 eye surgeries. Dr. Shi is truly one of the creators of this 
revolutionary technology by CRMI. 
 
*The manufacturer: *China Regenerative Medicine International Limited 
("CRMI") is a 20-year-old medical institution. Located in Hong Kong, CRMI 
has invested billions of dollars in regenerative medicine and tissue 
engineering products. 
 
With more than 10 year's persistent efforts in medical research, CRMI has 
become the #1 business entity in both regenerativemedicine and tissue 
engineering, as well as stem cell and other health care products. CRMI has a 
good number of production facilities 
all over china such as Xi'an, Shengzhen, Tianjing and Suzhou, etc. 
 
*CFDA approval: *With over 10 years painstaking effort, Acornea was finally 
Approved by China FDA in April 2015, CRMI is the sole patent owner of 
Acornea products and ready to commercialize the products for the benefit of 
those who suffer from the blind world, and Acornea will bring light back to 
their life again. 
 
*Final words:* As the Nobel Prize winner, Dr. Gilbert once said: "Within the 
next 50 years, the mankind will be able to develop all human organs." The 
China Regenerative Medicine International is now just doing that! Acornea, 
an absolute innovation, will bring light to the blind. Acorena transplant 
may also unprecedentedly eliminate the remedies of lifelong 
immunosuppression. 
 
For more information, please visit: crmi.hk/s/about_group.php 
 
China Regenerative Medicine International 
Telephone: [phone] 
Fax: [phone] 
E-mail:[e-mail] 
Address:10th floor, Dah Sing Financial Center,108 Gloucester Road Wanchai, 
Hong Kong 
 
Please also contact: 
 
XiaoLu Li: 
Tel: [phone] 
Mobil:[phone] 
Email: [e-mail] 
 
Chan Chun Fung: 
Tel: [phone] 
Email: Anthony.chan@ CRMI.hk 
 
Zhengkang Shao: 
Tel:[phone] 
Mobil: (852) 59195330 
Email: Shao [e-mail] 
 
Document: http://n.eqs.com/c/fncls.ssp?u=OXEUIGSHCY [1] 
Document title: CRMI: Acornea Conquers the Darkness Innovation brings light 
to the blind around the world 
 
17/10/2016 Dissemination of a Press Release, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
 
Media archive at www.todayir.com 
511845 17/10/2016 
 
 
1: http://public-cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=201f37f7bfe4408bc5c883e037dd0f2c&application_id=511845&site_id=vwd&application_name=news 
 

(END) Dow Jones Newswires

October 17, 2016 05:21 ET (09:21 GMT)